Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Knight Therapeutics Inc. Insider Profile
4 Followers
Knight Therapeutics Inc., Ten Percent Owner at Medexus Pharmaceuticals Inc, holds 1.94M shares in Crescita Therpeutc (Ticker: TSE:CTX), holds 10.37M shares in Medexus Pharmaceuticals Inc (Ticker: TSE:MDP). Most recently, Knight Therapeutics Inc. Sold ― shares of Crescita Therpeutc on Aug 13, 2019 for an estimated value of 22.00K.
Knight Therapeutics Inc. Medexus Pharmaceuticals Inc (MDP)Ten Percent Owner
Medexus Pharmaceuticals Inc (MDP)
Ten Percent Owner
Ranked #4,802 out of 99,137 Corporate Insiders
Profitable Transactions
19 out of 25 Profitable Transactions
Average Return
+15.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Knight Therapeutics Inc. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Knight Therapeutics Inc.
Knight Therapeutics Inc.'s Trading History
Medexus Pharmaceuticals Inc
Sep 20, 2018
Ten Percent Owner
Informative Sell
25.90K
C$16.80M
Crescita Therpeutc
Aug 13, 2019
Shareholder
Informative Sell
22.00K
C$812.91K
List of latest transactions for each holding click on a transaction to see Knight Therapeutics Inc.'s performance on stock
You May Also Like
Knight Therapeutics Inc. insider profile FAQ
What is the percentage of profitable transactions made by Knight Therapeutics Inc.?
The percentage of profitable transactions made by Knight Therapeutics Inc. is 76%.
What is the average return per transaction made by Knight Therapeutics Inc.?
The average return per transaction made by Knight Therapeutics Inc. is 15.00%.
What stocks does Knight Therapeutics Inc. hold?
Knight Therapeutics Inc. holds: TSE:MDP, TSE:CTX stocks.
What was Knight Therapeutics Inc.’s latest transaction?
Knight Therapeutics Inc. latest transaction was an Informative Sell of C$22.00K.
What was Knight Therapeutics Inc.'s most profitable transaction?
Knight Therapeutics Inc.’s most profitable transaction was an Informative Sell of TSE:CTX stock on July 27, 2019. The return on the trade was 55.30%.
What is Knight Therapeutics Inc.'s role in Medexus Pharmaceuticals Inc?
Knight Therapeutics Inc.'s role in Medexus Pharmaceuticals Inc is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.